Evidence map›Paper›PMID 31061095›Full record

ArticleMolecular and cellular biology2019

Myc Regulation of a Mitochondrial Trafficking Network Mediates Tumor Cell Invasion and Metastasis.

Ekta Agarwal, Brian J Altman, Jae Ho Seo, Irene Bertolini, Jagadish C Ghosh, Amanpreet Kaur, Andrew V Kossenkov, Lucia R Languino, Dmitry I Gabrilovich, David W Speicher and 2 more

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Mitochondrial fragmentation is crucial for c-Myc-driven hepatoblastoma-like liver tumors.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  14. Article
  15. Article
  16. Mitochondrial Fission and Fusion in Tumor Progression to Metastasis.Frontiers in cell and developmental biology · 2022
    Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ekta AgarwalProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.
Brian J AltmanDepartment of Biomedical Genetics, University of Rochester Medical Center, Rochester, New York, USA.
Jae Ho SeoProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.
Irene BertoliniProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.
Jagadish C GhoshProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.
Amanpreet KaurSchool of Engineering and Applied Science, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Andrew V KossenkovCenter for Systems and Computational Biology, The Wistar Institute, Philadelphia, Pennsylvania, USA.
Lucia R LanguinoProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.
Dmitry I GabrilovichProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.
David W SpeicherProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.
Chi V DangMolecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.
Dario C AltieriProstate Cancer Discovery and Development Program, The Wistar Institute, Philadelphia, Pennsylvania, USA daltieri@wistar.org.
The Wistar Institute · USUniversity of Pennsylvania · USUniversity of Rochester Medical Center · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Role of Runx2 in prostate tumorigenesis and metastasisP01CA140043 · NCI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2010 to 2021
$12.2M
Tumor PlasticityR35CA220446 · NCI · WISTAR INSTITUTE · PI ALTIERI, DARIO C · 2017 to 2023
$7.7M
MYC--TRANSCRIPTION AND INTERACTION WITH P107R01CA051497 · NCI · WISTAR INSTITUTE · PI DANG, CHI V. · 1995 to 2025
$5.3M
Integrin-mediated mechanisms of prostate cancer progressionR01CA224769 · NCI · THOMAS JEFFERSON UNIVERSITY · PI LANGUINO, LUCIA R. · 2018 to 2022
$2.0M
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center LevelR50CA211199 · NCI · WISTAR INSTITUTE · PI Andrew V Kossenkov · 2016 to 2026
$1.6M
Oncogenic Disruption of the Circadian Metabolic Cycle in CancerR00CA204593 · NCI · UNIVERSITY OF ROCHESTER · PI ALTMAN, BRIAN JAMES · 2018 to 2020
$747k
Purchase of a Q Exactive HF mass spectrometer system for metabolomicsS10OD023586 · OD · WISTAR INSTITUTE · PI SPEICHER, DAVID W. · 2017 to 2017
$600k
Purchase of a Seahorse Bioscience XF AnalyzerS10OD023658 · OD · WISTAR INSTITUTE · PI MURPHY, MAUREEN E. · 2017 to 2017
$188k
NCI NIH HHS P01 CA140043NCI NIH HHS P30 CA010815NCI NIH HHS R00 CA204593NCI NIH HHS R01 CA051497NCI NIH HHS R01 CA224769NCI NIH HHS R35 CA220446NCI NIH HHS R50 CA211199NIH HHS S10 OD023586NIH HHS S10 OD023658
6 · The paper itself

Abstract

The Myc gene is a universal oncogene that promotes aggressive cancer, but its role in metastasis has remained elusive. Here, we show that Myc transcriptionally controls a gene network of subcellular mitochondrial trafficking that includes the atypical mitochondrial GTPases RHOT1 and RHOT2, the adapter protein TRAK2, the anterograde motor Kif5B, and an effector of mitochondrial fission, Drp1. Interference with this pathway deregulates mitochondrial dynamics, shuts off subcellular organelle movements, and prevents the recruitment of mitochondria to the cortical cytoskeleton of tumor cells. In turn, this inhibits tumor chemotaxis, blocks cell invasion, and prevents metastatic spreading in preclinical models. Therefore, Myc regulation of mitochondrial trafficking enables tumor cell motility and metastasis.

Indexed as

Gene Regulatory NetworksAnimalsCell Line, TumorDynaminsGene Expression ProfilingGene Expression Regulation, NeoplasticHumansIntracellular Signaling Peptides and ProteinsKinesinsLiver NeoplasmsMaleMiceMitochondriaMitochondrial ProteinsNeoplasm InvasivenessNeoplasm TransplantationDNM1L protein, humanDynaminsIntracellular Signaling Peptides and ProteinsKIF5B protein, humanKinesinsMitochondrial ProteinsMYC protein, humanNerve Tissue ProteinsProto-Oncogene Proteins c-mycrho GTP-Binding ProteinsRHOT1 protein, humanRHOT2 protein, humanTRAK2 protein, humancell invasionmetastasismitochondriaMyc

Identifiers

PMID31061095
PMCPMC6597883
OpenAlexW2944718112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.